France Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 252 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

3 Healthcare Sector Review

3.1 Healthcare Sector Review

3.2 Healthcare Expenditure

3.3 Healthcare Infrastructure

3.3.1 Healthcare Personnel Data

3.3.2 Healthcare Facilities Data

3.4 Healthcare Policy

4 Wound Care Management in France

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in France

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Hemostats Overall Volume (2000-2012)

5.2.3 Tissue Sealants Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share (2005-2006)

5.5 Wound Closure Devices Company Share (2005-2006)

6 Ostomy in France

6.1 Ostomy Overall Revenue (2000-2012)

6.2 Ostomy Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advance Wound Management in Germany

7.1 Advanced Wound Management Overall Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management in France

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2005-2006)

8.5 Traditional Wound Management Company Share (2005-2006)

9 Compression Therapy in France

9.1 Compression Therapy Overall Revenue (2000-2012)

9.2 Compression Therapy Overall Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2000-2012)

9.5 Compression Therapy Company Share (2005-2006)

10 HARTMANN GROUP Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Incontinence Management

10.2.2 Operating Theater Management

10.2.3 Other GROUP Activities

10.2.4 Wound Management

10.2.5 Products

10.2.6 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 HARTMANN GROUP Strengths

10.4.2 HARTMANN GROUP Weaknesses

10.4.3 HARTMANN GROUP Opportunities

10.4.4 HARTMANN GROUP Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

10.6.1 Other Locations & Subsidiaries

10.7 Recent Developments

10.7.1 Mar 17, 2008: Hartmann Declares 2007 Results

10.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia

10.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm

10.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results

11 Coloplast A/S Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Medical Care

11.2.2 Major Products and Services

11.2.3 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Coloplast A/S Strengths

11.4.2 Coloplast A/S Weaknesses

11.4.3 Coloplast A/S Opportunities

11.4.4 Coloplast A/S Threats

11.5 Financial and Operational Review

11.5.1 Financial Statements

11.5.2 Financial Ratios

11.5.3 Share Holding Structure

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 Coloplast Sells Brachytherapy Business To Core Oncology

11.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies

11.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast’s Business Unit

11.7.4 McKesson Corporation Acquires Sterling Medical Services

11.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor

11.8 Recent Developments

11.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary

11.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results

11.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results

11.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results

11.8.5 May 15, 2007: Colplast Declares H1 2007 Results

11.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results

11.8.7 Dec 13, 2006: Coloplast Appoints New Chairman

11.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results

12 Ethicon, Inc. Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Products

12.3 Locations And Subsidiaries

12.3.1 Other Locations & Subsidiaries

12.4 Financial Deals Landscape

12.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON

12.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON

12.4.3 ETHICON Acquires Vascular Control Systems

12.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON

13 Baxter International, Inc. Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 BioScience

13.2.2 Medication Delivery

13.2.3 Renal

13.2.4 Products

13.2.5 History

13.3 Value Chain Analysis

13.3.1 Manufacturing

13.3.2 Product Development

13.3.3 Sales and Marketing

13.4 SWOT Analysis

13.4.1 Baxter International Inc. Strengths

13.4.2 Baxter International Inc. Weaknesses

13.4.3 Baxter International Inc. Opportunities

13.4.4 Baxter International Inc. Threats

13.5 Financial and Operational Review

13.6 Locations And Subsidiaries

13.7 Financial Deals Landscape

13.7.1 Baiyunshan And Baxter Form A Joint Venture In China

13.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

13.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

13.7.4 B. Braun Acquires Renal Therapy Business Of Baxter

13.7.5 Innovata signs a license agreement with Baxter International

13.7.6 Kuros Biosurgery Signs An Agreement With Baxter International

13.7.7 Gambro Signs An Agreement With Baxter

13.7.8 Baxter Healthcare And Gambro Enter Into An Agreement

13.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System

13.7.10 Baxter International And Kaketsuken Enter Into Agreement

13.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful

13.8 Recent Developments

13.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007

13.8.2 Dec 18, 2007: Baxter Elects CFO

13.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend

13.8.4 Aug 01, 2007: Baxter Elects New Board Director

13.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend

13.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization

13.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend

13.8.8 Nov 28, 2006: Baxter Announces Annual Dividend

13.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America

13.9 Baxter International Inc. Pipeline Products

13.9.1 Next-Generation Home Hemodialysis Machine

14 Smith & Nephew Plc Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Advanced Wound Management

14.2.2 Endoscopy

14.2.3 Reconstruction

14.2.4 Trauma and Clinical Therapies

14.2.5 Products

14.2.6 History

14.3 Value Chain Analysis

14.3.1 Manufacturing

14.3.2 Product Development

14.3.3 Sales and Marketing

14.4 SWOT Analysis

14.4.1 Smith & Nephew Plc Strengths

14.4.2 Smith & Nephew Plc Weaknesses

14.4.3 Smith & Nephew Plc Opportunities

14.4.4 Smith & Nephew Plc Threats

14.5 Financial and Operational Review

14.6 Locations And Subsidiaries

14.6.1 Other Locations & Subsidiaries

14.7 Financial Deals Landscape

14.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein

14.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services

14.7.3 Smith & Nephew Acquires Plus Orthopedics Holding

14.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement

14.7.5 Smith & Nephew Acquires BlueSky Medical Group

14.7.6 Smith & Nephew Enters Into An Agreement With Covalon

14.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories

14.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew

14.7.9 Smith & Nephew Acquires Osteobiologics

14.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement

14.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity

14.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew

14.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies

14.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft

14.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement

14.7.16 Smith & Nephew Acquires VERSAJET From HydroCision

14.7.17 Smith & Nephew Terminates Acquisition Of Biomet

14.8 Recent Developments

14.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend

14.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results

14.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation

14.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM

14.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails

14.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend

14.8.7 May 03, 2007: Smith & Nephew Appoints New CEO

14.9 Smith & Nephew Plc Pipeline Products

14.9.1 R3 Modular resurfacing Acetabular system

14.9.2 R3 Ceramic-on-ceramic Acetabular System

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Classification

15.1.2 Conformity Assessment Process

15.1.3 Registration Fee

15.1.4 Registration Period

15.2 Post Market Surveillance (PMS)

16 Pricing and Reimbursement

16.1 Pricing and Reimbursement Policies

17 Distribution Structure

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List of Tables

Table 1: Number of Doctors by Specialty in France, 2003-2007

Table 2: Number of Hospital Wards by Specialty in France, 2003-2007

Table 3: Wound Care Management, France, Overall Revenues ($ mn), 2000-2012

Table 4: Wound Care Management, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 5: Wound Care Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 6: Wound Care Management, France, Category Revenues ($ mn), 2000-2012

Table 7: Wound Care Management, France, Category Revenues ($ mn), Historic, 2000-2007

Table 8: Wound Care Management, France, Category Revenues ($ mn), Forecast, 2007-2012

Table 9: Wound Care Management, France, Category Volume (Units), 2000-2012

Table 10: Wound Care Management, France, Category Volume (Units), Historic, 2000-2007

Table 11: Wound Care Management, France, Category Volume (Units), Forecast, 2007-2012

Table 12: Wound Care Management in France, Overall, Company Share by Revenue ($ mn), 2005-2006

Table 13: Wound Closure Devices, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 14: Wound Closure Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 15: Wound Closure Devices, France, Revenue by Segment ($ mn), Historic, 2000-2007

Table 16: Wound Closure Devices, France, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 17: Skin Closure Devices, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 18: Skin Closure Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 19: Hemostats, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 20: Hemostats, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 21: Tissue Sealants, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 22: Tissue Sealants, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 23: Wound Closure Devices, France, Overall Volume (Units), Historic, 2000-2007

Table 24: Wound Closure Devices, France, Overall Volume (Units), Forecast, 2007-2012

Table 25: Skin Closure Devices, France, Overall Volume (Units), Historic, 2000-2007

Table 26: Skin Closure Devices, France, Overall Volume (Units), Forecast, 2007-2012

Table 27: Hemostats, France, Overall Volume (Units), Historic, 2000-2007

Table 28: Hemostats, France, Overall Volume (Units), Forecast, 2007-2012

Table 29: Tissue Sealants, France, Overall Volume (Units), Historic, 2000-2007

Table 30: Tissue Sealants, France, Overall Volume (Units), Forecast, 2007-2012

Table 31: Hemostats, France, Average Price ($), Historic, 2000-2007

Table 32: Hemostats, France, Average Price ($), Forecast, 2007-2012

Table 33: Tissue Sealants, France, Average Price ($), Historic, 2000-2007

Table 34: Tissue Sealants, France, Average Price ($), Forecast, 2007-2012

Table 35: Skin Closure Devices, France, Average Price ($), Historic, 2000-2007

Table 36: Skin Closure Devices, France, Average Price ($), Forecast, 2007-2012

Table 37: Wound Closure Devices, France, Distribution Share by Revenue ($ mn), 2005-2006

Table 38: Wound Closure Devices, France, Company Share by Revenue ($ mn), 2005-2006

Table 39: Ostomy, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 40: Ostomy, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 41: Ostomy, France, Overall Volume (Units), Historic, 2000-2007

Table 42: Ostomy, France, Overall Volume (Units), Forecast, 2007-2012

Table 43: Ostomy, France, Average Price ($), Historic, 2000-2007

Table 44: Ostomy, France, Average Price ($), Forecast, 2007-2012

Table 45: Ostomy, France, Distribution Share by Revenue ($ mn), 2005-2006

Table 46: Ostomy, France, Company Share by Revenue Advanced Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 47: Advanced Wound Management, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 48: Advanced Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 49: Advanced Wound Management, France, Overall Volume (Units), Historic, 2000-2007

Table 50: Advanced Wound Management, France, Overall Volume (Units), Forecast, 2007-2012

Table 51: Advanced Wound Management, France, Average Price ($), Historic, 2000-2007

Table 52: Advanced Wound Management, France, Average Price ($), Forecast, 2007-2012

Table 53: Advanced Wound Management, France, Distribution Share by Revenue ($ mn), 2005-2006

Table 54: Advanced Wound Management, France, Company Share by Revenue ($ mn), 2005-2006

Table 55: Traditional Wound Management, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 56: Traditional Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 57: Traditional Wound Management, France, Overall Volume (Units), Historic, 2000-2007

Table 58: Traditional Wound Management, France, Overall Volume (Units), Forecast, 2007-2012

Table 59: Traditional Wound Management, France, Average Price ($), Historic, 2000-2007

Table 60: Traditional Wound Management, France, Average Price ($), Forecast, 2007-2012

Table 61: Traditional Wound Management, France, Distribution Share by Revenue ($ mn), 2005-2006

Table 62: Traditional Wound Management, France, Company Share by Revenue ($ mn), 2005-2006

Table 63: Compression Therapy, France, Overall Revenues ($ mn), Historic, 2000-2007

Table 64: Compression Therapy, France, Overall Revenues ($ mn), Forecast, 2007-2012

Table 65: Compression Therapy, France, Overall Volume (Units), Historic, 2000-2007

Table 66: Compression Therapy, France, Overall Volume (Units), Forecast, 2007-2012

Table 67: Compression Therapy, France, Average Price ($), Historic, 2000-2007

Table 68: Compression Therapy, France, Average Price ($), Forecast, 2007-2012

Table 69: Compression Therapy, France, Distribution Share by Revenue ($ mn), 2005-2006

Table 70: Compression Therapy, France, Company Share by Revenue ($ mn), 2005-2006

Table 71: HARTMANN GROUP, SWOT Analysis, 2006

Table 72: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006

Table 73: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006

Table 74: HARTMANN GROUP, Subsidiaries

Table 75: Coloplast A/S, SWOT Analysis, 2007

Table 76: Coloplast A/S, Financial Statements, DKK Million, 2003-2007

Table 77: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007

Table 78: Coloplast A/S, Share Holding Structure

Table 79: Coloplast A/S, Other Locations

Table 80: Coloplast A/S, Subsidiaries

Table 81: Coloplast A/S, Subsidiaries (Contd.)

Table 82: Ethicon, Inc., Other Locations

Table 83: Ethicon, Inc., Subsidiaries

Table 84: Baxter International Inc., SWOT Analysis, 2006

Table 85: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 86: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 87: Baxter International Inc., Other Locations

Table 88: Baxter International Inc., Subsidiaries

Table 89: Smith & Nephew Plc, SWOT Analysis, 2006

Table 90: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006

Table 91: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006

Table 92: Smith & Nephew Plc, Other Locations

Table 93: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.2 List of Figures

Figure 1: Total Healthcare Expenditure in France, 2000 - 2006

Figure 2: Wound Care Management, France, Overall Revenues ($ mn), 2000-2012

Figure 3: Wound Care Management, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 4: Wound Care Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 5: Wound Care Management, France, Category Revenues ($ mn), 2000-2012

Figure 6: Wound Care Management, France, Category Revenues ($ mn), Historic, 2000-2007

Figure 7: Wound Care Management, France, Category Revenues ($ mn), Forecast, 2007-2012

Figure 8: Wound Care Management, France, Category Volume (Units), 2000-2012

Figure 9: Wound Care Management, France, Category Volume (Units), Historic, 2000-2007

Figure 10: Wound Care Management, France, Category Volume (Units), Forecast, 2007-2012

Figure 11: Wound Care Management in France, Overall, Company Share (%), 2006

Figure 12: Wound Closure Devices, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 13: Wound Closure Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 14: Wound Closure Devices, France, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 15: Wound Closure Devices, France, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 16: Skin Closure Devices, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 17: Skin Closure Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 18: Hemostats, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 19: Hemostats, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 20: Tissue Sealants, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 21: Tissue Sealants, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 22: Wound Closure Devices, France, Overall Volume (Units), Historic, 2000-2007

Figure 23: Wound Closure Devices, France, Overall Volume (Units), Forecast, 2007-2012

Figure 24: Skin Closure Devices, France, Overall Volume (Units), Historic, 2000-2007

Figure 25: Skin Closure Devices, France, Overall Volume (Units), Forecast, 2007-2012

Figure 26: Hemostats, France, Overall Volume (Units), Historic, 2000-2007

Figure 27: Hemostats, France, Overall Volume (Units), Forecast, 2007-2012

Figure 28: Tissue Sealants, France, Overall Volume (Units), Historic, 2000-2007

Figure 29: Tissue Sealants, France, Overall Volume (Units), Forecast, 2007-2012

Figure 30: Hemostats, France, Average Price ($), Historic, 2000-2007

Figure 31: Hemostats, France, Average Price ($), Forecast, 2007-2012

Figure 32: Tissue Sealants, France, Average Price ($), Historic, 2000-2007

Figure 33: Tissue Sealants, France, Average Price ($), Forecast, 2007-2012

Figure 34: Skin Closure Devices, France, Average Price ($), Historic, 2000-2007

Figure 35: Skin Closure Devices, France, Average Price ($), Forecast, 2007-2012

Figure 36: Wound Closure Devices, France, Distribution Share (%), 2006

Figure 37: Wound Closure Devices, France, Company Share (%), 2006

Figure 38: Ostomy, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 39: Ostomy, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 40: Ostomy, France, Overall Volume (Units), Historic, 2000-2007

Figure 41: Ostomy, France, Overall Volume (Units), Forecast, 2007-2012

Figure 42: Ostomy, France, Average Price ($), Historic, 2000-2007

Figure 43: Ostomy, France, Average Price ($), Forecast, 2007-2012

Figure 44: Ostomy, France, Company Share (%), 2006

Figure 45: Advanced Wound Management, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 46: Advanced Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 47: Advanced Wound Management, France, Overall Volume (Units), Historic, 2000-2007

Figure 48: Advanced Wound Management, France, Overall Volume (Units), Forecast, 2007-2012

Figure 49: Advanced Wound Management, France, Average Price ($), Historic, 2000-2007

Figure 50: Advanced Wound Management, France, Average Price ($), Forecast, 2007-2012

Figure 51: Advanced Wound Management, France, Distribution Share (%), 2006

Figure 52: Advanced Wound Management, France, Company Share (%), 2006

Figure 53: Traditional Wound Management, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 54: Traditional Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 55: Traditional Wound Management, France, Overall Volume (Units), Historic, 2000-2007

Figure 56: Traditional Wound Management, France, Overall Volume (Units), Forecast, 2007-2012

Figure 57: Traditional Wound Management, France, Average Price ($), Historic, 2000-2007

Figure 58: Traditional Wound Management, France, Average Price ($), Forecast, 2007-2012

Figure 59: Traditional Wound Management, France, Distribution Share (%), 2006

Figure 60: Traditional Wound Management, France, Company Share (%), 2006

Figure 61: Compression Therapy, France, Overall Revenues ($ mn), Historic, 2000-2007

Figure 62: Compression Therapy, France, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 63: Compression Therapy, France, Overall Volume (Units), Historic, 2000-2007

Figure 64: Compression Therapy, France, Overall Volume (Units), Forecast, 2007-2012

Figure 65: Compression Therapy, France, Average Price ($), Historic, 2000-2007

Figure 66: Compression Therapy, France, Average Price ($), Forecast, 2007-2012

Figure 67: Compression Therapy, France, Distribution Share (%), 2006

Figure 68: Compression Therapy, France, Company Share (%), 2006

Figure 69: HARTMANN GROUP, Value Chain Analysis

Figure 70: Coloplast A/S, Value Chain Analysis

Figure 71: Baxter International Inc., Value Chain Analysis

Figure 72: Smith & Nephew Plc, Value Chain Analysis

Figure 73: Flowchart for Classification of Non-invasive Devices in France, 2007

Figure 74: Flowchart for Classification of Invasive Devices in France, 2007

Figure 75: Flowchart for Classification of Invasive Devices in France, 2007

Figure 76: Flowchart for Classification of Invasive Devices in France, 2007

Figure 77: Flowchart for Classification of Invasive Devices in France, 2007

Figure 78: Flowchart for Classification of Active Devices in France, 2007

Figure 79: Flowchart for Classification of Active Devices in France, 2007

Figure 80: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in France, 2007

Figure 81: Conformity Assessment of Class-I Medical Devices in France, 2007

Figure 82: Conformity Assessment of Class-IIa Medical Devices in France, 2007

Figure 83: Conformity Assessment of Class-IIb Medical Devices in France, 2007

Figure 84: Conformity Assessment of Class-III Medical Devices in France, 2007

Figure 85: Medical Equipment Distribution Structure in France, 2007

Figure 86: Global Markets Direct Methodology

Abstract

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.